Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03740490 · ClinicalTrials.gov registry record · Phase 2
Smartphone Based Smoking Cessation Intervention
A Phase 2 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 2
- Development phase
- 454
- Enrollment target
NCT03740490 is a Phase 2 study that has completed, run by University of Oklahoma. The registered enrollment target is 454 participants.
The verdict
NCT03740490, a Phase 2 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 454 participants
- Enrollment target
Study Summary
Smoking is becoming increasingly concentrated among individuals with the lowest levels of income, education, and occupational status. In fact, smoking rates in the United States among people living below the poverty line is nearly twice as high as those above the poverty threshold. Highly flexible and low burden technology-based treatment approaches may overcome many of the barriers that have limited the use and effectiveness of traditional smoking cessation treatments among low socioeconomic status (SES) adults. Ecological momentary assessment (EMA), in which mobile devices are used to capture moment-to-moment experiences, allows for the measurement of phenomena in real-time within natural settings. Smartphone-based smoking cessation apps could offer easily accessible, highly tailored, and intensive interventions at a fraction of the cost of traditional smoking cessation counseling. The Smart-T app uses a lapse risk estimator to identify moments of heightened risk for lapse, and the algorithm tailors treatment messages in real-time based upon level of imminent smoking lapse risk and currently present lapse triggers. This study will compare smoking cessation rates for those randomized to the Smart-T app or the NCI QuitGuide app.
Interventions
- COMBINATION_PRODUCT QuitGuide + NRT
- COMBINATION_PRODUCT Smart-T + NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2023-11-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03740490
The ClinicalTrials.gov registry entry for NCT03740490 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 454 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which QuitGuide + NRT is the first listed.
NCT03740490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03740490 about?
NCT03740490 is a clinical study titled "Smartphone Based Smoking Cessation Intervention". Smoking is becoming increasingly concentrated among individuals with the lowest levels of income, education, and occupational status. In fact, smoking rates in the United States among people living below the poverty line is nearly twice as high as those above the poverty threshold. Highly flexible a...
What is the current status of trial NCT03740490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 454 participants. The study started on 2019-08-26. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT03740490?
The interventions under investigation include: QuitGuide + NRT (COMBINATION_PRODUCT), Smart-T + NRT (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03740490?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.